MIDTERM 04 - Diuretics Flashcards
Basic unit of the kidneys
Nephron
3 steps of urine formation (GTT)
Glomerular filtration, Tubular reabsorption, Tubular secretion
Forerunners of diuretics; blocks carbonic anhydrase; its segment is the PCT (Types of diuretics)
Carbonic anhydrase inhibitors
2 most common carbonic anhydrase inhibitors; used for the reduction of aqueous humor production in glaucoma (DB)
Dorzolamide, Brinzolamide
Contraindication for carbonic anhydrase inhibitors
Liver cirrhosis
Used for reduction of intraocular pressure (IOP) and intracranial pressure (ICP); its segment is the PCT and descending LoH (Types of diuretics)
Osmotic diuretics
Prototype drug of osmotic diuretics
Mannitol (IV)
Mannitol (IV) and urea are examples of __________
Osmotic diuretics
High-ceiling, most efficacious diuretics; blocks the luminal NKCC2; its segment is the thick ascending limb of LoH (Types of diuretics)
Loop diuretics
Its most important use is for acute pulmonary edema and peripheral edema (Types of diuretics)
Loop diuretics
Blocks NCC; its segment is the DCT (Types of diuretics)
Thiazide diuretics
Prototype drug of thiazide diuretics
Hydrochlorothiazide
Parent compound of thiazide diuretics
Chlorothiazide
Hydrochlorothiazide and chlorothiazide are examples of __________
Thiazide diuretics
Chlorthalidone, indapamide, and metolazone are examples of __________
Thiazide-like diuretics
Thiazide diuretics are ineffective at GFT <30 to 40 mL/mine, except ___________ and __________ (MI)
Metolazone, Indapamide
A thiazide-like diuretic that is more potent; acts both on PCT and DCT (Types of diuretics)
Metolazone
Its segment is the collecting tubules and ducts; used for primary and secondary hyperaldosteronism and Liddle syndrome (Types of diuretics)
K+ sparing diuretics
2 K+ sparing diuretics that are steroidal MRAs (SE)
Spironolactone, Eplerenone
3 K+ sparing diuretics that are nonsteroidal MRAs (FEA)
Finerenone, Esaxerenone, Apararenone
2 K+ sparing diuretics that block Na+ entry in the epithelial Na+ channels (ENAC) (AT)
Amiloride, Triamterene
Spironolactone, eplerenone, triamterene, and amiloride are examples of __________
K+ sparing diuretics
Inhibits SGLT-2; its segment is the PCT (Types of diuretics)
SGLT-2 inhibitors
Dapagliflozin, canagliflozin, empagliflozin, ertugliflozin, and ipragliflozin are examples of __________
SGLT-2 inhibitors
SGLT-2 inhibitors are used for __________; they reduce CV death and hospitalization regardless of presence or absence of DM
HFrEF
Considered as a 3rd-line therapy for DM (Types of diuretics)
SGLT-2 inhibitors
SGLT-2 inhibitors are __________; they reduce CV mortality, nonfatal stroke, and nonfatal MI
Cardioprotective
SGLT-2 inhibitors are __________; they protect against declining renal function, ESRD, death due to kidney disease, and AKI
Renoprotective
Cardiac atria (Natriuretic peptide)
Atrial NP
Cardiac ventricles (Natriuretic peptide)
Brain NP
CNS, Kidneys (Natriuretic peptide)
C-type NP
Kidneys (Natriuretic peptide)
Urodilatin
Cardiac atria (Recombinant analog)
Carperitide
Cardiac ventricles (Recombinant analog)
Nesiritide
Kidneys (Recombinant analog)
Ularitide
Binds to NP receptors (NPRs); its segment is the intramedullary collecting duct (Types of diuretics)
Natriuretic peptides
NPR A and B are __________ receptors
Guanylyl cyclase
Used for acute decompensated HF w/ dyspnea at rest or minimal activity (Examples of natriuretic peptides)
Nesiritide
Is studied in acute HF (Examples of natriuretic peptides)
Ularitide
A 1:1 mixture of 8-bromotheophylline and 2-amino-2-methyl-1-propanol (Examples of adenosine antagonists)
Pamabrom
Are nonselective adenosine receptor antagonists; examples include caffeine, theophylline, and theobromine (Examples of adenosine antagonists)
Methylxanthines
4 adenosine receptors
A1, A2a, A2b, A3
Adenosine receptor found in pre-glomerular afferent arteriole (decreases RBF and GFR) and PCT (stimulates NHE3 and Na+ reabsorpstion)
A1
Blocks A1 receptors causing diuresis w/o K+ wasting; its segment is PCT; used as OTC for premenstrual syndrome (Types of diuretics)
Adenosine antagonists
Used in refractory patients to loop diuretics alone (Diuretic combinations)
Loop + Thiazides
Used in preventing hypokalemia; avoided in renal insufficiency and in ACEI recipients (Diuretic combinations)
K+ sparing + CA inhibitors/Loop/Thiazides
Used in renal failure w/ very low GFR (Diuretic combinations)
Furosemide + Metolazone
Heart failure (Edematous or non-edematous state)
Edematous
Renal failure (Edematous or non-edematous state)
Edematous
Liver cirrhosis (Edematous or non-edematous state)
Edematous
Idiopathic edema (Edematous or non-edematous state)
Edematous
Hypertension (Edematous or non-edematous state)
Non-edematous
Nephrolithiasis (Edematous or non-edematous state)
Non-edematous
Hypercalcemia (Edematous or non-edematous state)
Non-edematous
Diabetes insipidus (Edematous or non-edematous state)
Non-edematous
Renoprotection and cardioprotection (Edematous or non-edematous state)
Non-edematous
Used for severe edema (Heart failure - diuretics used)
Loop + Thiazide
Used to correct alkalosis (Heart failure - diuretics used)
Loop + CA inhibitor
Used to correct alkalosis and hypokalemia (Heart failure - diuretics used)
Loop + K+ sparing
Enhances K+ excretion and used for hyperkalemia (Renal failure - diuretics used)
Thiazide/Loop diuretic
Used to control the volume-dependent component of hypertension of nephrotic syndrome (Renal failure - diuretics used)
Loop diuretic
Used for treatment of volume overload in dialysis or predialysis patients (Renal failure - diuretics used)
High-dose furosemide/Furosemide + Metolazone
Exacerbates acidosis (Renal failure - diuretics used)
Acetazolamide
Causes hyperkalemia (Renal failure - diuretics used)
K+ sparing diuretics
Ineffective at GFR <30 mL/min; can be used to reduce the dose of loop diuretics (Renal failure - diuretics used)
Thiazide diuretics
Ineffective because of decreased secretion of the drug into the tubular fluid (Hepatic cirrhosis - diuretics used)
Loop diuretics
Is effective; has potential for causing serious hyperkalemia (Hepatic cirrhosis - diuretics used)
MRAs
Relative contraindication for hepatic cirrhosis; is effective but increases liver function tests
Vaptans
2 ADRs from excessive diuretic use for hepatic cirrhosis (HH)
Hepatorenal syndrome, Hepatic encephalopathy
Edema characterized by fluctuating salt retention and edema
Idiopathic edema
Idiopathic edema is sometimes treated with ____________
Spironolactone
Used as the 1st-line diuretic for essential hypertension; enhances the efficacy of ACE inhibitors (Hypertension - diuretics used)
Thiazide diuretics
More effective than HCTZ due to long half life but has more adverse effects (Hypertension - diuretics used)
Chlorthalidone
Reserved for patients with mild renal insufficiency or heart failure (Hypertension - diuretics used)
Loop diuretics
Used to reduce K+ wasting (Hypertension - diuretics used)
K+ sparing diuretics
May be the most effective single agent in the therapy of drug-resistant hypertension (Hypertension - diuretics used)
Spironolactone
Enhances Ca2+ reabsorption in the DCT and reduces the urinary Ca2+ concentration (Nephrolithiasis - diuretics used)
Thiazide diuretics
Reduces Ca2+ reabsorption significantly and effectively promoting Ca2+ diuresis (Hypercalcemia - diuretics used)
Loop diuretics
__________ is treated with ADH analogs (Types of diabetes insipidus)
Neurogenic/Central DI
Can reduce polyuria and polydipsia; blocks Li-induced NDI (Diabetes insipidus - diuretics used)
Thiazide diuretics
Blocks Li induced polyuria (Diabetes insipidus - diuretics used) (AT)
Amiloride, Triamterene
Are efficacious in reducing polyuria w/ fever adverse effects (Diabetes insipidus - diuretics used)
Acetazolamide
Cardioprotective in patients w/ heart disease (Renoprotection and cardioprotection - diuretics used)
MRAs
Carbonic anhydrase inhibitors (MOA)
Blocks carbonic anhydrase
Carbonic anhydrase inhibitors (Segment)
PCT
Osmotic diuretics (Segment)
PCT and descending LoH
Loop diuretics (MOA)
Blocks NKCC2
Loop diuretics (Segment)
Thick ascending limb of LoH
Thiazide diuretics (MOA)
Blocks NCC
Thiazide diuretics (Segment)
DCT
K+ sparing diuretics (MOA)
Blocks ENaC
K+ sparing diuretics (Segment)
Collecting tubules and ducts
SGLT-2 inhibitors (MOA)
Inhibits SGLT-2
SGLT-2 inhibitors (Segment)
PCT
Natriuretic peptides (MOA)
Binds to NP receptors (NPRs)
Natriuretic peptides (Segment)
Intramedullary collecting duct
Adenosine antagonists (MOA)
Blocks A1 receptors
Adenosine antagonists (Segment)
PCT